Research Journal
Deep dives into the pharmacology, biology, and application of kappa-opioid receptor agonists.
Essential tips for laboratory managers on verifying supplier credibility, demanding purity data, and ensuring reliable sourcing.
Looking ahead at the research pipeline: how KOR agonism and antagonism are shaping the future of psychiatric and analgesic medicine.
A comprehensive FAQ covering the chemistry, legal status, handling, and application of SR-17018 in research settings.
An educational deep dive into endogenous dynorphins, how they regulate mood and stress, and their connection to SR-17018.
Understanding analytical testing methods, Certificates of Analysis, and why ≥99% purity is non-negotiable for valid research.
Examining the paradigm shift in pharmacological research as science moves away from mu-opioids toward novel targets like KOR.
How targeting kappa-opioid receptors outside the brain provides powerful pain relief for inflammatory conditions.
A deep dive into functional selectivity—how SR-17018 triggers specific cellular responses to maximize benefits and minimize side effects.
A comprehensive guide on the definition, handling, and ethical compliance of using SR-17018 as a research chemical.
Understanding the context of the opioid epidemic and why compounds like SR-17018 represent hope for the future of pain management.
How biased agonism separates the analgesic benefits of KOR activation from the debilitating dysphoric side effects seen in older compounds.
Exploring how the endogenous dynorphin/KOR system regulates stress responses and what SR-17018 reveals about anxiety pathways.
An overview of dosing parameters and scaling considerations utilized in current SR-17018 research models.
Essential guidelines for maintaining the purity and stability of SR-17018 research compounds in your laboratory.
A practical guide for researchers on choosing between raw SR-17018 powder and pre-measured capsules for laboratory protocols.
How SR-17018 is changing the landscape of non-addictive pain management research, specifically in visceral and inflammatory pain models.
A direct comparison between traditional mu-opioid drugs and the kappa-selective research compound SR-17018.
Dive deep into the biology of kappa-opioid receptors, their natural ligands, and their role in pain, stress, and mood.
Exploring the potential of SR-17018 in addiction research. How targeting the KOR system might offer new hope for treating opioid use disorder.
An in-depth look at SR-17018, its discovery, mechanism of action, and why it represents a major breakthrough in kappa-opioid receptor research.